Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with I / Ibudilast 		 
Ibudilast
  

Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan.
CategoriesVasodilator Agents
Platelet Aggregation Inhibitors
Phosphodiesterase Inhibitors
Bronchodilator Agents
Synonyms2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine
3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine
AV-411
Eyevinal
I0157_SIGMA
Ibudilast (jan/inn)
Ibudilast [inn:jan]
Ibudilastum
Ibudilastum [latin]
Ke tas
Ketas
Ketas (TN)
Lopac-I-0157
MN-166
Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-
Tocris-1694
UNII-M0TTH61XC5

indication

For the treatment of multiple sclerosis, asthma, and cerebrovascular disease.

mechanism of action

Ibudilast has mechanisms that include anti-inflammatory effects, such as phosphodiesterase inhibition, and neuroprotective effects, such as inhibition of [nitric oxide] synthesis and reduction in reactive oxygen species.

toxicity

Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia

half life

19 hours

Terms of Use